MedPath

JANSSEN-CILAG FARMACEUTICA LTDA

🇧🇷Brazil
Ownership
-
Employees
-
Market Cap
-
Website

An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.

Phase 3
Completed
Conditions
Binge Eating
First Posted Date
2006-03-28
Last Posted Date
2011-01-31
Lead Sponsor
Janssen-Cilag Farmaceutica Ltda.
Target Recruit Count
73
Registration Number
NCT00307619
© Copyright 2025. All Rights Reserved by MedPath